About
Hugues Wallemacq is a Belgian life-sciences investor-operator and biotech executive. He is publicly listed as Investment Manager at Noshaq and has served as CEO of EXO Biologics and Man & Science. His background spans veterinary medicine, immunology, diagnostics, vaccines, and exosome-based therapeutics.
Areas of interest
biotechexosomescell therapyadvanced therapy medicinal productsdrug deliverydiagnosticsrespiratory diseaseinflammatory bowel diseaseneurologyoncologylife sciences commercialization